Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec:208:1-3.
doi: 10.1016/j.thromres.2021.10.002. Epub 2021 Oct 9.

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study

Carmen Rodríguez  1 , Alberto Pérez-Nieva  2 , Luis Máiz  1 , María Del Mar Meijón  3 , Pilar Llamas  4 , Manuel Monreal  5 , Behnood Bikdeli  6 , David Jiménez  7
Affiliations
Comment

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study

Carmen Rodríguez et al. Thromb Res. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

  • Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA. Schultz NH, et al. N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9. N Engl J Med. 2021. PMID: 33835768 Free PMC article.

References

    1. Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 2020;383:2603–2615. - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021;384:403–416. - PMC - PubMed
    1. Voysey M., Costa Clemens S.A., Madhi S.A., et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397:881–891. - PMC - PubMed
    1. Sadoff J., Gray G., Vandebosch A., et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N. Engl. J. Med. 2021;384:2187–2201. - PMC - PubMed
    1. Schultz N.H., Sorvoll I.H., Michelsen A.E., et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV vaccination. N. Engl. J. Med. 2021;384:2124–2130. - PMC - PubMed